[Federal Register Volume 59, Number 53 (Friday, March 18, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-6370]


[[Page Unknown]]

[Federal Register: March 18, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Health Care Policy and Research

 

Public Meeting on Medical Treatment Effectiveness Research: 
Hysterectomy and Other Therapies Used in the Management of Common 
Noncancerous Uterine Conditions

AGENCY: Agency for Health Care Policy and Research, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting on the subject of Medical 
Treatment Effectiveness Research: Hysterectomy and Other Therapies Used 
in the Management of Common Noncancerous Uterine Conditions.

DATES: The meeting, open to the public, will be on Monday, May 9, 1994 
from 8 a.m. to 5 p.m. and Tuesday, May 10, 1994 from 8 a.m. to 5 p.m.

ADDRESSES: The meeting will be at the Garden City Hotel, Garden City, 
Long Island, New York, 11530.

SUPPLEMENTARY INFORMATION:

I. Purpose

    Section 1142 of the Social Security Act (42 U.S.C. 1320b-12) 
authorizes the Agency for Health Care Policy and Research (AHCPR) to 
conduct and support research on the outcomes, effectiveness, and 
appropriateness of health care services and procedures in order to 
identify the manner in which diseases, disorders, and other health 
conditions can most effectively and appropriately be prevented, 
diagnosed, treated, and managed clinically. The Medical Treatment 
Effectiveness Program (MEDTEP) is described in the Catalog of Federal 
Domestic Assistance, No. 93.180.
    The purpose of this meeting is to conduct a critical review and 
discussion of the current science related to treatment effectiveness 
for common noncancerous uterine conditions, and to recommend to AHCPR 
appropriate and feasible medical effectiveness research strategies for 
the future. Topics will address what scientific evidence is available 
and what is known and not known about the effectiveness and outcomes of 
treatments for specific clinical conditions. These common conditions 
include dysfunctional uterine bleeding and pain, uterine prolapse (with 
and without urinary dysfunction), endometriosis, and leiomyomata 
(fibroids). The examination of treatment alternatives will include but 
not be limited to hysterectomy (including all surgical techniques), 
hormone therapy, other pharmacotherapy, laser technology, myomectomy, 
and watchful waiting.

II. Agenda

    The opening plenary session will begin at 8 a.m. on May 9, 1994, 
and provide an overview of the topic and expectations for the meeting. 
Presentations, which will focus on: (1) Clinical perspectives and 
issues, (2) economic issues associated with treatment alternatives, and 
(3) issues in measurement of clinical, psychological, functional, and 
other outcomes, will follow with open discussion periods. Working 
groups will meet concurrently in the afternoon.
    A second set of working groups will meet concurrently on Tuesday, 
May 10, 1994. These groups will make reports and recommendations at the 
conclusion of the meeting.

III. Arrangements for the May 9-10, 1994 Meeting

    Individuals and representatives of organizations who would like to 
attend the meeting must register by April 15, 1994 with Kristine 
Krutules, Walcoff & Associates, the contractor providing administrative 
support to AHCPR for the meeting, at the address set out below. 
Registration information and a draft agenda may be obtained by writing 
to Walcoff & Associates, Attention: Kristine Krutules, 635 Slaters 
Lane, suite 400, Alexandria, Virginia 22314. Requests for registration 
materials may also be submitted by facsimile transmission at 703-548-
0426, Attention: Kristine Krutules. Facsimile cover sheets should 
include a name, address, telephone number, and facsimile number to 
which materials may be transmitted.
    If sign language interpretation or other reasonable accommodation 
for a disability is needed, please contact Walcoff & Associates, 
Attention Kristine Krutules by April 15, 1994 at the address listed 
above.
    Individuals and representatives of organizations may provide 
relevant written comments and information on hysterectomy and common 
noncancerous uterine conditions to Walcoff & Associates by April 22, 
1994. Copies of this information will be made available to the 
participants at the meeting.
    Additional information on the meeting can be obtained by contacting 
Jane D. Scott, Sc.D., Health Scientist Administrator, Center for 
Medical Effectiveness Research, Agency for Health Care Policy and 
Research, at the following address: Jane D. Scott, Sc.D., Coordinator, 
``MEDTEP Conference: Uterine Conditions'', 2101 East Jefferson Street, 
suite 605, Rockville, Maryland 20852, Phone: 301-594-1485, FAX: 301-
594-3211.

    Dated: March 11, 1994.
J. Jarrett Clinton,
Administrator.
[FR Doc. 94-6370 Filed 3-17-94; 8:45 am]
BILLING CODE 4160-90-P